Stryker マネジメント

マネジメント基準チェック /34

Strykerの CEO はKevin Loboで、 Oct2012年に任命され、の在任期間は 12.08年です。の年間総報酬は$ 20.77Mで、 6.7%給与と93.3%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.026%を直接所有しており、その価値はMX$ 763.70M 。経営陣と取締役会の平均在任期間はそれぞれ6.2年と6.5年です。

主要情報

Kevin Lobo

最高経営責任者

US$20.8m

報酬総額

CEO給与比率	6.7%
CEO在任期間	12.1yrs
CEOの所有権	0.03%
経営陣の平均在職期間	6.2yrs
取締役会の平均在任期間	6.5yrs

経営陣の近況

Recent updates

CEO報酬分析

Stryker の収益と比較して、Kevin Lobo の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	US$4b
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

報酬と市場: Kevinの総報酬 ($USD 20.77M ) は、 MX市場 ($USD 5.70M ) の同規模の企業の平均を上回っています。

報酬と収益: Kevinの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Kevin Lobo (59 yo)

12.1yrs

在職期間

US$20,767,847

報酬

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Kevin Lobo	Chairman	12.1yrs	US$20.77m	0.026% MX$ 763.7m
Glenn Boehnlein	VP & CFO	8.6yrs	US$6.84m	0.0011% MX$ 33.3m
Viju Menon	Group President of Global Quality & Operations	6.6yrs	US$4.47m	0.0024% MX$ 70.3m
J. Pierce	Group President of MedSurg & Neurotechnology	6.3yrs	US$6.49m	0.015% MX$ 441.6m
Spencer Stiles	Group President of Orthopaedics & Spine	6.3yrs	US$6.49m	0.014% MX$ 401.4m
William Berry	VP & Chief Accounting Officer	3.3yrs	データなし	0.00078% MX$ 22.6m
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	データなし	データなし
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	6.2yrs	データなし	データなし
Jason Beach	Vice President of Finance & Investor Relations	2.3yrs	データなし	データなし
Robert Fletcher	VP & Chief Legal Officer	5.6yrs	US$2.24m	0.0024% MX$ 70.9m
Dana McMahon	VP & Chief Compliance Officer	no data	データなし	データなし
Yin Becker	VP of Communications	5.9yrs	データなし	0.0087% MX$ 251.5m

6.2yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: SYK *の経営陣は経験豊富で経験豊富です（平均在職期間は6.2年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Kevin Lobo	Chairman	12.1yrs	US$20.77m	0.026% MX$ 763.7m
Lisa Skeete Tatum	Independent Director	4.5yrs	US$319.25k	0.00085% MX$ 24.6m
Howard Cox	Director Emeritus	6.5yrs	US$38.86k	データなし
John Brown	Chairman Emeritus	no data	US$286.99k	5.26% MX$ 152.3b
Ronda Stryker	Independent Director	40.8yrs	US$319.25k	4.83% MX$ 139.7b
Mary Brainerd	Independent Director	7.3yrs	US$334.25k	0.0015% MX$ 44.3m
Allan Golston	Independent Director	13.8yrs	US$334.25k	0.0039% MX$ 113.2m
Sherilyn S. McCoy	Lead Independent Director	6.5yrs	US$359.25k	0.00022% MX$ 6.4m
Rajeev Suri	Independent Director	6.5yrs	US$319.25k	0.0014% MX$ 39.6m
Giovanni Caforio	Independent Director	3.9yrs	US$319.25k	0.00067% MX$ 19.4m
Andrew Silvernail	Independent Director	11yrs	US$339.25k	0.0015% MX$ 42.3m
Rachel Ruggeri	Independent Director	less than a year	データなし	0.000010% MX$ 289.4k

6.5yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: SYK *の取締役会は経験豊富であると考えられます ( 6.5年の平均在任期間)。

Stryker マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Independent Director recently sold Mex$1.7b worth of stock

Key Executive recently sold Mex$4.2m worth of stock

VP & CFO recently sold Mex$127m worth of stock

VP & CFO recently sold Mex$55m worth of stock

Insufficient new directors

Insufficient new directors

Recent updates

Independent Director recently sold Mex$1.7b worth of stock

Third quarter 2024 earnings released: EPS: US$2.19 (vs US$1.82 in 3Q 2023)

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

Key Executive recently sold Mex$4.2m worth of stock

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Second quarter dividend of US$0.80 announced

Stryker Announces Launch of Pangea Plating System

VP & CFO recently sold Mex$127m worth of stock

Second quarter 2024 earnings released: EPS: US$2.17 (vs US$1.94 in 2Q 2023)

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

VP & CFO recently sold Mex$55m worth of stock

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$2.07 (vs US$1.56 in 1Q 2023)

Insufficient new directors

Insufficient new directors

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Upcoming dividend of US$0.80 per share

Insufficient new directors

Fourth quarter dividend of US$0.80 announced

Independent Director recently sold Mex$1.7b worth of stock

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Full year 2023 earnings released: EPS: US$8.34 (vs US$6.24 in FY 2022)

Stryker Corporation Provides Earnings Guidance for the Year 2024

Insufficient new directors

Upcoming dividend of US$0.80 per share at 1.0% yield

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

VP & Chief Accounting Officer recently sold Mex$2.9m worth of stock

Independent Director recently sold Mex$8.8m worth of stock

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$1.82 (vs US$2.16 in 3Q 2022)

Stryker to Showcase Q Guidance System with Spine Guidance Software

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Stryker Corporation Provides Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: EPS: US$1.94 (vs US$1.73 in 2Q 2022)

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

Independent Director recently sold Mex$5.1m worth of stock

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$1.56 (vs US$0.85 in 1Q 2022)

Stryker’s Q Guidance System for Cranial Applications Receives FDA Clearance

Independent Director recently sold Mex$2.7b worth of stock

Stryker Declares Quarterly Dividend, Payable on April 28, 2023

VP & CFO recently sold Mex$127m worth of stock

Full year 2022 earnings released: EPS: US$6.24 (vs US$5.29 in FY 2021)

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q4, 2022 Results on Jan 31, 2023

Stryker Launches Citrefix™ Suture Anchor System

Investor sentiment improved over the past week

Stryker Corporation Declares Quarterly Dividend, Payable January 31, 2023

マネジメント基準チェック /34